H
Health Care Family Rehab & Research Center | Hialeah, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Pregabalin
MLE4901
LF111
Oxycodone
Drospirenone
Bococizumab
Naloxone
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 6 total trials
The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD)...
Enrolling
Change in Bone Mineral Density
Bone Loss
Drug: LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet
Trial sponsors
I
M
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems